Roche, PathAI partner to boost the adoption of Digital Pathology backed by Cloud
Key Insights and Signals – Hospital & Healthcare
Centre setup and expansion Mayo Clinic in Florida invests over USD 400 Mn in expansions The investment is split among five projects, including an oncology facility and a five-floor addition to Mayo Clinic North. Other significant projects in the pipeline include the expansion of an emergency department, the construction of a hotel on its campus, and an 866-space parking garage for its patients. Read More>> Apollo Hospitals launches Centre of Excellence in Critical Care (ACECC) The ACECC will harness emerging technologies to create an integrated network of eICUs providing world-class critical care across the Apollo Hospitals network and in partnership with non-Apollo units in India and abroad. The ACECC will comprise tech-enabled Critical Care Units (CCUs) supported by intelligent solutions. Read More>>Deal and Deal Renewal Atlantic Health System picks Syft Synergy platform for supply chain management Syft will provide supply chain visibility across the entire Atlantic Health System enterprise and help the health system transition to Oracle SCM Cloud. The Syft Synergy platform, integrated with Oracle SCM Cloud, provides hospitals with complete traceability and visibility into supplies and resources. Read More>> UnityPoint Health selects b.well Connected Health to power its digital transformation b.well provides a mobile and centralized location where consumers can manage every aspect of their health. With this, UnityPoint wants to focus on the patient and make their overall healthcare experience easier and more personal, similar to the digital experience they’re accustomed to with shopping, travel, and other aspects of their life. Read More>> Mayo Clinic taps Personalis for genome sequencing to guide cancer therapy and R&D Personalis’ cancer test will be used to fully sequence the genetic code of a patient’s tumor and provide a clinical report for Mayo’s oncologists. Mayo hopes to put Personalis to work in expanding genomic testing to diverse patient populations that have not yet had access to the benefits of sequencing and personalized medicine. Read More>>Partnerships Swiss Re partners with Wysa for mental health app The partnership will see Wysa create an insurance-specific app that helps consumers better track their mental wellbeing and improve links to insurers’ existing support networks, such as therapy providers or employee assistance programs. The new app will include mental health tracking and guidance for seeking offline support and better reporting for insurance clients. Read More>> Nemours Children’s Health chooses Innovaccer to support a value-based healthcare model The company will leverage the Innovaccer Health Cloud for clinical and financial insights for 50,000+ patients in their network. The Health Cloud’s advanced analytics can use this unified patient data to generate clinical and business insights that support effective cost, utilization, and risk management across multiple provider and payer contracts. Read More>> Cleveland Clinic and RubiconMD partner to advance access to specialty expertise Cleveland Clinic will utilize RubiconMD’s eConsult Platform to connect primary care clinicians to a panel of its multidisciplinary experts. The tech-enabled joint solution enables clinicians to streamline their workflows, obtain continuing education from top experts and deliver more value to their patients. Read More>>Executive Movement Anthem Inc. announces changes to the Leadership Pete Haytaian will lead Anthem’s diversified business group and IngenioRx as Executive VP and President. Morgan Kendrick will lead Anthem’s commercial business as Executive VP and President, joining Anthem’s Senior Leadership Team. Rajeev Ronanki has been named President of Digital Platforms. Read More>> Fran Bruce appointed as Aviva’s new MD of protection Bruce, who has been with Aviva for the past 18 years and currently occupies the role of Managing Director of Existing Customer Management, will lead the protection business for both individual and group following Rob Barker’s move to Aviva’s savings and retirement business in April this year. Read More>> Cincinnati COO to become CEO Steve Davis, who has served as the health system’s COO for the past six years, will begin to lead the organization on November 22. During his tenure as COO, Davis served as interim CEO for six months during 2018. Before joining Cincinnati Children’s, Davis served as COO of Hillcrest Hospital, a part of the Cleveland Clinic health system. Read More>>Mergers and Acquisitions Marshfield Clinic to acquire Dickinson County Health System (DCHS) The deal will fold DCHS into the Marshfield Clinic system. The companies will work to expand primary care and pediatric along with expanding Emergency services. Read More>> Jefferson Health, Einstein Healthcare finalize the merger, create an 18-hospital system The USD 599 Mn deal will add Einstein’s three acute care hospitals and a rehab hospital to Jefferson’s hospital network. The combination of the Philadelphia-based organizations also brings together two academic medical centers and creates an integrated 18-hospital system with more than 50 outpatient and urgent care locations. Read More>>
Key Insights and Signals in Medical Devices
Deal and Deal Renewal Randox opens 10 new adaptive cube laboratories Based on a modular format, sites can be operational within weeks and be redeployed if required. The laboratories will initially be used to enhance the UK’s COVID-19 testing capacity during the winter, with each lab’s daily capacity of 12,000 tests combining to bring online an additional 120,000 COVID samples per day. Read More>> MilliporeSigma opens a second manufacturing facility in Carlsbad This is the company’s second Carlsbad facility to serve cell and gene therapy customers driven by the industry’s rapid adoption of viral vector-based therapies. Between the two facilities, there are 30 cleanroom suites to support all aspects of manufacturing, from small to large-scale clinical and commercial production. Read More>>Partnerships PathAI and Roche team up to push adoption of digital pathology tech The collaboration will initially involve the distribution of PathAI-developed research-use-only (RUO) algorithms through NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise software, focusing on immuno-oncology in multiple cancer types. Read More>> CGI and GE Healthcare partner to support rapid digitization The work undertaken by the two companies will help UK cities and towns to become smarter and more connected with healthcare systems. The integration will improve the experience for both patients and clinicians, with enhanced quality of care and better working practices at the core of the partnership’s aims. Read More>> Cypress Creek EMS, Siemens Healthineers partner to bring prehospital blood analysis to patients The new partnership will allow emergency medical technicians to analyze patients’ blood before reaching the hospital. Siemens Healthineers’ blood analysis system works by scanning a patient’s secure ID, examining a small blood sample, and instantly delivering results allowing emergency medical technicians to use the data to make treatment decisions. Read More>>Executive Movement Johnson & Johnson appoints Jessica Moore as VP of Investor Relations Ms. Moore brings over 20 years of strong financial experience spanning sales operations, corporate, and regional positions. Most recently, Ms. Moore served as the VP and CFO for the Janssen Pharmaceutical business in the EMEA Region, where she played a critical role in analyzing financial performance, assessing risks and opportunities, and maintaining a robust and compliant environment. Read More>> Orthofix Medical names finance exec to the board The company has appointed Wayne C. Burris to its Board of Directors and audit and finance committee. From 1996 until his retirement in 2019, Burris served as Roche’s Senior VP and CFO. He also led the company as a member of the global Roche diagnostics finance executive committee. Read More>>Mergers and Acquisition Boston Scientific to buy Baylis Medical for USD 1.75 Bn The acquisition is expected to generate net sales of almost USD 200 Mn in 2022. The deal is expected to close in the first quarter of next year. Baylis received U.S. clearance for its NRG platform in 2008, and the technology has been used in more than one million procedures. Read More>> Laborie Inc. acquires Pelvalon for its MedTech device Eclipse Pelvalon has developed an innovative product called the Eclipse™ System, a non-surgical, patient-controlled device for women suffering from fecal incontinence (FI). FI is a pelvic floor disorder that affects one in ten women. Read More>> Hologic to acquire Bolder Surgical for USD 160 Mn Bolder Surgical’s laparoscopic vessel sealing, dividing, and dissecting devices will join Hologic’s surgical portfolio when the deal closes, expected by the end of 2021. The recent acquisition will help Hologic expand its core GYN surgical portfolio and further diversify its product offerings. Read More>>
Key Insights and Signals in Pharmaceutical
Centre setup and expansion Cambrex to invest USD 30 Mn to expand manufacturing Center of Excellence The expansion will add new chemistry laboratories, two new clinical manufacturing suites, and a small-scale commercial manufacturing operation with three work centers and 2,000 Litre reactors. This investment is crucial to provide Cambrex with the capabilities to handle the latest R&D process research tools and techniques. Read More>> Merck expands with a new manufacturing facility for gene therapy This new USD 100 Mn, 140,000-square foot facility will more than double the company’s existing capacity to support large-scale commercial and industrial manufacturing for viral gene therapy, in a market expected to grow to USD 10 Bn by 2026. The investment serves in addressing larger patient populations with new curative treatments. Read More>> Bayer announces investment in new production capabilities for Reversible Contraceptives The company will invest over USD 460 Mn as part of its commitment to providing 100 Mn women in low- and middle-income countries access to modern contraception by 2030. The investment will include expanding production capabilities in Turku, Finland, and constructing a new production site in Alajuela, Costa Rica. Read More>>Deal and Deal Renewal Olix signs a tech export contract with Jiangsu Hansoh Under the agreement, the two companies plan to discover therapeutic substances for cardiovascular and metabolic diseases based on Olix’s GalNAc-asiRNA platform technology and develop therapeutics using Hansoh’s R&D, manufacturing, and commercialization capabilities. Read More>>Partnerships Eli Lilly, Cipla partner to enhance access to Lilly’s key diabetes products As a part of this agreement, Lilly will transfer its rights in India to sell, promote and distribute the aforesaid two Lilly diabetes products – Humalog and Trulicity to Cipla, subject to all regulatory approvals. Lilly will continue to maintain its existing operating model for the remaining portfolio of products. Read More>> Elanco and KSU forge a strategic partnership The partnership will focus on collaborative research and licensing of intellectual property for use in commercial animal health initiatives. Researchers at Elanco and KSU will delve into sustainable livestock production and pet health practices, vector-borne and emerging disease prevention and treatment, and understanding various animal microbiomes. Read More>> Novartis announces partnership in multiple sclerosis with Innodem Neurosciences The company will fund a clinical trial using Innodem’s AI-powered eye-tracking technology, capable of capturing and analyzing Eye Movement Biomarkers (EMBs) and Gaze Mapping Biomarkers (GMBs) to assist a clinician’s diagnosis and monitor disease progression. Read More>>Mergers and Acquisition Alexion concludes Caelum acquisition for USD 500 Mn The acquisition is in accordance with the development, option, and stock purchase agreement (DOSPA) entered by Fortress Biotech, Caelum, Alexion, and others. Read More>> Novartis’s Sandoz completes purchase of GSK’s cephalosporin business Sandoz paid USD 350 Mn at closing, plus additional milestone payments will be made of up to USD 150 Mn. Through this transaction, Sandoz has acquired rights to three brands – Zinnat, Zinacef, and Fortum – in more than 100 markets, further reinforcing its global position in antibiotics. Read More>> Syneos Health buys RxDataScience to scale up data science capabilities RxDataScience built a scalable platform for biopharmaceutical companies to transform vast volumes of data into strategic, actionable insights. Post this acquisition, Syneos expects to offer biopharma customers technology-enabled, insights-powered solutions to accelerate performance across the product lifecycle – from lab to life. Read More>>Executive Movement TherapeuticsMD appoints Mark Glickman as Chief Business Officer Mr. Glickman previously served as Chief Commercial Officer of Esperion and Aralez Pharmaceuticals and Executive VP of Sales and Marketing at Auxilium Pharmaceuticals. Mr. Glickman received his MBA in Finance and International Management from New York University and his BA from State University of New York College at Oswego. Read More>>
Latest Industry Insights from Draup Braindesk
Use cases of IoT:
Hospital and Healthcare:
Patient health monitoring, real-time hospital bed tracking, and medicine adherence tracking are some of the significant IoT use-cases assisting healthcare providers in delivering better care.
UCHealth partnered with BioIntelliSense to use medical-grade sensors that effortlessly capture remote patient data and generate personalized clinical intelligence.
Medline and VitalTech are working together to bring virtual care and remote patient monitoring (RPM) to physician offices throughout the USA.
Pharmaceuticals:
Startups are offering solutions for early detection of equipment defects, drug tracking, and medical adherence for the pharmaceutical industry.
Novartis and AWS collaborated for pharmaceutical manufacturing, supply chain, and delivery operations. Using AWS, Novartis can collect inventory, quality, and production data across its network and apply AWS IoT and ML services to gain visibility and help drive efficiencies.
Bayer and Tempus partner to advance patient access to genomic testing and precision medicine. It provides broader access to genomic testing and tailored treatment approaches for the oncology community.
Key Funding Alert
Chance Pharmaceuticals secures USD 30 Mn Series C Funding
The new funds will be used to advance the company’s research and development efforts for its innovative pipeline of inhalation therapies, initiate additional business collaborations and accelerate the construction of a manufacturing facility. Read More>>
Startup Spotlight
Company – Attune Neurosciences Total Funding– USD 3.75 Mn About: Attune Neurosciences is a medical device company dedicated to developing novel solutions for central nervous system disorders with clinically-proven, non-invasive neurostimulation products. Read More>>
Latest Reports Published in Draup
Bupa Account Intelligence Report:Bupa aims to improve private healthcare services and health insurance solutions. It aims to utilize cloud technology and enhance its wellness engagement platform as it partners with key tech players. Read More>>
GSK Europe Account Intelligence Report: GSK focuses on developing next-generation mRNA vaccines for Covid 19 and supports high-quality scientific research investigating the link between genetic diversity across regions. Another focus area remains on science related to the immune system, human genetics, and advanced technology. Read More>>
Here’s what’s new on our Sales Intelligence Platform Track Digital Tech Stack Changes Through Homepage Feed
Get to know digital tech stack changes made by accounts in your lists through homepage feed
You can view the user access change history in the Users section under the Administration
Sales
